EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)

K Jagathesan, Sovan Roy iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400127 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, 2024. Verfasst von K Jagathesan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Chemistry, School of Advance Sciences, Vellore Institute of Technology, Vellore, 632014, India. Hauptthemen laut MEDLINE: Prodrugs, Coordination Complexes, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: VIT, Vellore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia is a state characterized by low concentration of Oxygen. Hypoxic state is often found in the central region of solid tumors. Hypoxia is associated with abnormal neovascularization resulted in poor blood flow in tissues and increased proliferation of tumor cells, imbalance between O 2 supply and O 2 consumption in tumor cells, high concentration of proton and strong reducibility. And, these abnormalities enhance the survival potency of the hypoxic tumours and increase the resistance towards chemotherapy and radiotherapy. One of the approach for treating hypoxic region of tumour is to use reducing environment of hypoxic tumours for reducing a molecule (hypoxia activated prodrug, HAP) and as a result the active drug will be released in hypoxic region in a controlled manner from the prodrug and kill the hypoxic tumour. Co(III) and Pt(IV) complexes with monodentate active drug molecule in the axial position can be reduced to Co(II) and Pt(II) moieties and as a result, the axial ligands (active drug) could come out from the metal center and could show its anticancer activity. In this review we have highlighted the research articles where transition metal‐based complexes are used as chemotherapeutic hypoxia activated prodrug molecules which are reported in last 5 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsCoordination ComplexesAntineoplastic AgentsHumansTransition ElementsNeoplasmsCell ProliferationMolecular StructureDrug Screening Assays, AntitumorAnimals

Substanzen

ProdrugsCoordination ComplexesAntineoplastic AgentsTransition Elements

Autor:innen und Institutionen

  • Dept. of Chemistry, School of Advance Sciences, Vellore Institute of Technology, Vellore, 632014, India.

ORCID-Profile: Sovan Roy

Förderung

  • VIT, Vellore

Zitieren

APA

Jagathesan, K., & Roy, S. (2024). Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP). ChemMedChem. https://doi.org/10.1002/cmdc.202400127

Vancouver

Jagathesan K, Roy S. Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP). ChemMedChem. 2024. doi:10.1002/cmdc.202400127

BibTeX
@article{Jagathesan2024,
  author = {Jagathesan, K and Roy, Sovan},
  title = {Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400127}
}
Kostenlos starten →